Completed OBSERVATIONAL NCT03920475

The Role of Inflammatory Processes in Development and Treatment of Depression (INFLAME-D)

An Investigation of the Role of Inflammatory Processes in the Development and Treatment of Idiopathic Unipolar and Bipolar Depression in Patients With Moderate to Severe Depressive Symptoms.

Sponsor: Créteil Hospital

Conditions Depression Depressive Disorder Inflammation

Interventions Immune parameters Sertraline or venlafaxine

Updated 7 times since 2019 Last updated: Feb 10, 2020 Started: Aug 5, 2015 Primary completion: Mar 6, 2018 Completion: Mar 6, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Depression and Depressive Disorder and is currently completed. Créteil Hospital leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Mar 2020 — Nov 2020 [monthly]

Completed
May 2019 — Mar 2020 [monthly]

Completed

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Créteil Hospital
German Federal Ministry of Education and Research
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Kliniken Essen-Mitte
Ministry of Health, Italy
National Research Agency, France
Ruhr University of Bochum
University of Bordeaux

Data source: Kliniken Essen-Mitte

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.